A phase I trial of ACH 2684 in healthy volunteers and patients with hepatitis C virus genotypes 1 or 3.

Trial Profile

A phase I trial of ACH 2684 in healthy volunteers and patients with hepatitis C virus genotypes 1 or 3.

Completed
Phase of Trial: Phase I

Latest Information Update: 20 Feb 2013

At a glance

  • Drugs Deldeprevir (Primary)
  • Indications Hepatitis C
  • Focus Adverse reactions
  • Most Recent Events

    • 20 Feb 2013 Status changed from recruiting to completed as reported in an Achillion media release.
    • 12 Nov 2012 Beneficial results in genotype-1 hepatitis C treatment-naive patients with cirrhosis were reported in an Achillion Pharmaceuticals media release.
    • 09 Jan 2012 Results were presented in an Achillion Pharmaceuticals media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top